Phase II trial of celecoxib in combination with paclitaxel and carboplatin in advanced non-small cell lung cancer
Tanaffos. 2007; 6 (1): 37-46
in En
| IMEMR
| ID: emr-85413
Responsible library:
EMRO
Search on Google
Index:
IMEMR
Main subject:
Pyrazoles
/
Carboplatin
/
Treatment Outcome
/
Paclitaxel
/
Drug Therapy, Combination
/
Drug-Related Side Effects and Adverse Reactions
/
Cyclooxygenase 2
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
En
Journal:
Tanaffos
Year:
2007